If this box remains here for more than 30 seconds, click this link to try again.
Industries
Functions
Home » Products & Services » Best Practice Database » Product Launch » Market Entry and Oncology
Download FREE Excerpt
21 Info Graphics
29 Data Graphics
200+ Metrics
12 Narratives
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Buy Now
STUDY OVERVIEW
New oncology products are constantly entering the biopharmaceutical marketplace; some therapies are immediate successes while others flounder for months. While there are a myriad of factors that go into preparing a new oncology pharmaceutical product for market entry, one of the key selling points is a product's characteristics. Thus, how an oncology product differentiates itself from existing therapies, how it is priced in the market and its benefits - ease of use, fewer side effects, etc. - are all important factors that shape a new oncology product's market entry. Best Practices, LLC conducted this study to highlight the effectiveness of different tactics regarding differentiation, pricing and product benefits. The study also reviews issues surrounding a product's safety and efficacy profile to determine how much more effective or safe a new oncology product needs to be to have a successful market entry. Launch leaders can use this research as part of building their market entry strategy for new oncology products.
This study includes two segments: one representing the entire benchmark class and one representing the oncology therapeutic area. KEY TOPICS
The research employed a data gathering approach that gleaned quantitative data from 44 executives and managers from 38 leading companies in pharmaceutical, biotechnology and medical device industries. In addition, six executives participated in in-depth interviews.
If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.
Top